KAW comments to FDA docket on ADUFA data collection. FDA should expand its request for animal drug sales data in order to comply with the Congressional purpose of helping to “determine how resistant bugs [bacteria] are developing and inform research on ways to stop those bugs from threatening human health.” This means collecting data on medicated feeds and designing the method of submission in a manner that ensures that it can meet the needs of regulatory authorities and external researchers.